Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Aeon Biopharma, Inc.

NYSE: AEON · Life Sciences · 5 alerts · CIK 1837607

Share price
$0.1407Close, Nov 16
Market cap
$11.8M
Shares outstanding
84.12MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Aeon Biopharma, Inc. filings on SEC EDGAR ↗

8:01 AM ET 8-K
Business Update

Aeon Biopharma Business Update

AEON Biopharma received official minutes from a Type 2b meeting with the FDA regarding the biosimilar development pathway for ABP-450, a proposed biosimilar to BOTOX. The FDA agreed in principle with a proposed two-stage pharmacodynamic study design, and the company plans to submit an IND for this study in Q4 2026 with initiation expected in Q1 2027. The feedback supports a potentially streamlined development path that may leverage existing comparative human evidence to avoid or narrow the scope of standalone comparative efficacy studies.

Counterparty
FDA

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.